Announced details
Pharmaceutical industry; B2B payments between pharmaceutical manufacturers and pharmaceutical wholesalers
Pharmaceutical manufacturers' receivables collection periods will be shortened and centralized to as little as 30 days. Pharmaceutical wholesalers will, in principle, be able to maintain their existing payment terms and bank transfer timing.
アルファリア will partner with both companies. アルファリア is a wholly owned subsidiary of TOHO HOLDINGS CO.,LTD. Infcurion,Inc. provides an invoice payment platform, while Sumitomo Mitsui Card Company, Limited provides card issuance and acquiring functions.
Infcurion,Inc.: Headquartered in Chiyoda-ku, Tokyo; President and CEO Maruyama Koki (丸山弘毅); established on 1 May 2006; provides platforms and consulting services focused primarily on financial services and payments. Sumitomo Mitsui Card Company, Limited: Headquartered in Koto-ku, Tokyo; President Sasaki Takeya (佐々木丈也); established on 26 December 1967; engaged in credit card operations and various payment services.
In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.
| Item | Details |
|---|---|
| Names of Products / Services Covered | Pharma Trade Pay (provisional name), Winvoice (invoice payment platform) |
| Counterparty | Infcurion,Inc., Sumitomo Mitsui Card Company, Limited |
| Counterparty overview | Infcurion,Inc.: Headquartered in Chiyoda-ku, Tokyo; President and CEO Maruyama Koki (丸山弘毅); established on 1 May 2006; provides platforms and consulting services focused primarily on financial services and payments. Sumitomo Mitsui Card Company, Limited: Headquartered in Koto-ku, Tokyo; President Sasaki Takeya (佐々木丈也); established on 26 December 1967; engaged in credit card operations and various payment services. |
| Relationship with the Company | アルファリア will partner with both companies. アルファリア is a wholly owned subsidiary of TOHO HOLDINGS CO.,LTD. Infcurion,Inc. provides an invoice payment platform, while Sumitomo Mitsui Card Company, Limited provides card issuance and acquiring functions. |
| Launch date | Scheduled to launch on 7 October 2026 |
| Applicable area | Pharmaceutical industry; B2B payments between pharmaceutical manufacturers and pharmaceutical wholesalers |
| Quantitative Effects | Pharmaceutical manufacturers' receivables collection periods will be shortened and centralized to as little as 30 days. Pharmaceutical wholesalers will, in principle, be able to maintain their existing payment terms and bank transfer timing. |
Items this document does not state (11)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To resolve the complexity of pharmaceutical manufacturers' receivables collection and cash flow management arising from collection periods that differ by pharmaceutical wholesaler. The service will also allow payment methods to be changed while limiting the impact on wholesalers' existing payment terms and cash flow management.